LY-2365109

LY-2365109
Names
	IUPAC name 2-[2-[4-(1,3-Benzodioxol-5-yl)-2-tert-butylphenoxy]ethyl-methylamino]acetic acid
Identifiers
3D model (JSmol)	Interactive image;
PubChem CID	11552757;
	SMILES CC(C)(C)C1=C(C=CC(=C1)C2=CC3=C(C=C2)OCO3)OCCN(C)CC(=O)O;
Properties
Chemical formula	C22H27NO5
Molar mass	385.460 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

LY-2365109 is a glycine reuptake inhibitor. It is able to inhibit the type 1 glycine transporter.^[1] This inhibition increases extracellular levels of glycine. LY-2365109 has been shown to increase the seizure threshold in mice, meaning that this drug has potential as an anticonvulsant.^[2]

References

^ Zhang, Jichun; Wu, Jin; Toyohara, Jun; Fujita, Yuko; Chen, Hongxian; Hashimoto, Kenji (2011). "Pharmacological characterization of [³H]CHIBA-3007 binding to glycine transporter 1 in the rat brain". PLOS ONE. 6 (6): e21322. Bibcode:2011PLoSO...621322Z. doi:10.1371/journal.pone.0021322. ISSN 1932-6203. PMC 3121759. PMID 21731704.
^ Shen, Hai-Ying; van Vliet, Erwin A.; Bright, Kerry-Ann; Hanthorn, Marissa; Lytle, Nikki K.; Gorter, Jan; Aronica, Eleonora; Boison, Detlev (December 2015). "Glycine transporter 1 is a target for the treatment of epilepsy". Neuropharmacology. 99: 554–565. doi:10.1016/j.neuropharm.2015.08.031. ISSN 1873-7064. PMC 4655139. PMID 26302655.

This article about an organic compound is a stub. You can help Wikipedia by expanding it.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[1] Zhang, Jichun; Wu, Jin; Toyohara, Jun; Fujita, Yuko; Chen, Hongxian; Hashimoto, Kenji (2011). "Pharmacological characterization of [³H]CHIBA-3007 binding to glycine transporter 1 in the rat brain". PLOS ONE. 6 (6): e21322. Bibcode:2011PLoSO...621322Z. doi:10.1371/journal.pone.0021322. ISSN 1932-6203. PMC 3121759. PMID 21731704.

[2] Shen, Hai-Ying; van Vliet, Erwin A.; Bright, Kerry-Ann; Hanthorn, Marissa; Lytle, Nikki K.; Gorter, Jan; Aronica, Eleonora; Boison, Detlev (December 2015). "Glycine transporter 1 is a target for the treatment of epilepsy". Neuropharmacology. 99: 554–565. doi:10.1016/j.neuropharm.2015.08.031. ISSN 1873-7064. PMC 4655139. PMID 26302655.

[1]

[2]